Every year, drug manufacturers lose roughly $8.5 billion paying out duplicate drug discounts, like those that overlap between the Medicaid Drug Rebate Program and the 340B Drug Pricing Program.  While this kind of double-dipping is prohibited by the programs, inadequate infrastructure and administrative challenges can make such duplicates hard to avoid. And manufacturers have to absorb the cost.

Join us as we walk through how to assess your organization’s needs in a drug discount management program, define its structure, and build on its strengths for a more impactful and cost-effective initiative. You’ll learn:

• Benefits and considerations across programs with different levels of engagement and review
• Best practices for developing an audit program for drug discount management
• The role technology can play in discount management
• Anecdotes and case studies of these tips in action